KIT and systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease: Additional non-KIT mutations are frequently identified in patients with SM-AHN and mainly consist of mutations in TET2, SRSF2, ASXL1, RUNX1, N/KRAS, or IDH2 [21].